Celemics셀레믹스
331920 · KOSDAQ · ₩331920 · 셀레믹스
₩9,220▲ ₩610 (7.08%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩5.8B | ₩6.7B | ₩6.6B | ₩8.7B | ₩8.1B |
| Cost of sales | ₩2.9B | ₩3B | ₩5.1B | ₩6.3B | ₩5.3B |
| Gross profit | ₩2.9B | ₩3.7B | ₩1.5B | ₩2.4B | ₩2.8B |
| Operating income | −₩3.3B | −₩1.9B | −₩5.8B | −₩5.7B | −₩6B |
| Net income | −₩4B | ₩12B | −₩3.9B | −₩4.8B | −₩5.2B |
| Net income to shareholders | −₩4B | ₩12B | −₩3.9B | −₩4.8B | −₩5.2B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩24B | ₩29B | ₩18B | ₩22B | ₩27B |
| Current assets | ₩8.4B | ₩12B | ₩13B | ₩16B | ₩23B |
| Cash and equivalents | ₩3.2B | ₩4B | ₩2.6B | ₩2.3B | ₩6B |
| Total liabilities | ₩1.4B | ₩2.2B | ₩2.2B | ₩3.6B | ₩3.5B |
| Current liabilities | ₩1.3B | ₩2B | ₩1.6B | ₩2.6B | ₩2B |
| Borrowings | ₩377M | ₩518M | ₩866M | ₩1.2B | ₩0 |
| Total equity | ₩23B | ₩27B | ₩16B | ₩19B | ₩23B |
| Shareholders' equity | ₩23B | ₩27B | ₩16B | ₩19B | ₩23B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩3.6B | −₩380M | −₩4.5B | −₩4.1B | −₩3.2B |
| Capital spending | ₩166M | ₩117M | ₩219M | ₩545M | ₩568M |
| Free cash flow | −₩3.8B | −₩497M | −₩4.8B | −₩4.7B | −₩3.8B |
Consolidated where available. Amounts in won.
Also known as: Celemics / 셀레믹스 / 331920 / KRX:331920
Source: KRX statistical information